NCT03704077 · Interventional trial
An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Overall registry status Withdrawn
Phase 2
Conditions Cancer of the Stomach, Gastric Cancer, Gastroesophageal Junction, Stomach Cancer
Delaware Valley sites
- Local Institution · New Brunswick, NJ · Camden County
First posted
Registry updated
Added to the directory